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Background: To evaluate the impact of the presence of endometrioma and laparoscopic cystectomy on ovarian
reserve as assessed by serum anti-Müllerian hormone (AMH) level. In addition, factors related to the decline in ovarian
reserve were analyzed.
Methods: From June 2013 to January 2014, we prospectively included 40 women with endometriomas as the study
group (group A), 36 women with tubal factor infertilities as control group 1 (group B) and 22 women with the other
benign ovarian cysts as control group 2 (group C). The women with ovarian cysts underwent laparoscopic cystectomy.
Serum AMH levels were determined preoperatively and at 1 month after surgery.
Results: The endometrioma group had lower AMH levels (1.53 ± 1.37 ng/ml) compared with the other benign ovarian
cyst group (2.20 ± 1.23 ng/ml) and the tubal factor infertility group (2.82 ± 1.74 ng/ml). The rate of serum AMH decline
1 month after surgery in the endometrioma group (0.62 ± 0.35) was larger than the decline in the other benign
ovarian cyst group (0.32 ± 0.30). The preoperative AMH level showed a significant correlation with patient age
(group A, r = −0.32; group B, r = −0.54; group C, r = −0.71); there was a statistically significant correlation between
the rate of serum AMH decline and endometrioma diameter as well as with the preoperative serum AMH level. In
addition, the rate of serum AMH decline was larger for bilateral endometriomas than for unilateral endometriomas, but
there was no similar correlation in the other benign ovarian cyst group. The rate of AMH decline after surgery in the
subgroup of >7 cm was significantly higher than in the subgroup of ≤7 cm.
Conclusions: Ovarian endometriomas per se may damage ovarian reserve, and cystectomy of endometriomas may
cause greater damage to ovarian reserve compared with other benign ovarian cysts. The operation-related damage to
the ovarian reserve was positively related to whether the endometriomas were bilateral, as well as cyst size (especially for
cysts >7 cm), but was negatively related to the preoperative serum AMH level. Age was a negative factor that affected
the ovarian reserve.
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Endometriosis is an enigmatic disease characterized by
the development of the endometrial tissue outside of the
uterus. The most common location of endometriosis is the
ovary, occurring in 17-44% of patients affected by endomet-
riosis [1]. Laparoscopic excision of endometriomas is
regarded as a first-line treatment, but the reduced number
of retrieved oocytes for in vitro fertilization and premature
ovarian failure after surgery reported in several papers
have raised concerns [2,3]. Because endometriosis is most
common in reproductive-age women, it is important to
predict and protect the patients’ ovarian function. Ovarian
reserve is defined as the functional potential of the ovary,
and it reflects the number and quality of the follicles
left in the ovary at any given time. At present, the ideal
test reflecting ovarian reserve remains the serum anti-
Müllerian hormone (AMH) level, which has equal sen-
sitivity and specificity to the antral follicle count (AFC)
and is better than follicle-stimulating hormone (FSH),
estradiol, luteinizing hormone (LH), FSH/LH ratio or
inhibin-B levels [4]. Moreover, the serum AMH level
appears to be independent of the menstrual cycle and is
not affected by the use of gonadotropin-releasing hormone
(GnRH) agonists or oral contraceptives [5-8]. It is worth-
while and convenient to elucidate changes in ovarian re-
serve as measured by serum AMH level, which reflects the
count of primordial follicles, after ovarian surgery.
To date, there have been several studies of the effect
of laparoscopic cystectomy on ovarian reserve, but con-
troversies still exist. There are no definitive data to clarify
whether the damage to the ovarian reserve observed in pa-
tients with endometriomas is related to the surgical proced-
ure, to the previous presence of a cyst, or both. It is also
unclear what the risk factors for damage to the ovarian
reserve after surgery are.
Thus, our prospective cohort study analyzed the pre-
operative serum AMH level and changes in the serum
AMH level after surgery in the endometrioma group by
comparing these patients with tubal factor infertility pa-
tients and patients with other benign ovary cysts to identify
differences in the preoperative serum AMH levels, changes
after surgery and the determinants of surgery-related
changes on ovarian reserve.
Methods
Patients
The present prospective cohort study recruited a total of
98 women who underwent laparoscopic surgery due to
endometriomas (n = 40), other benign ovarian cysts (n = 22;
18 teratomas, 2 mucinous cystadenomas and 2 serous
cystadenomas) and tubal factor infertility (n = 36) from
June 2013 to January 2014 at the Department of Obstetrics
and Gynecology of the First Affiliated Hospital of Sun
Yat-sen University in Guangzhou, China. All the patientswith endometriomas or other benign ovarian cysts were
confirmed by pathology. And the routine approach for
tubal factor infertility was as follows: 1. history; 2. ultra-
sound; 3. sex hormone and ovulation supervision; 4. sperm
analysis; and 5. hysteroscopy, laparoscopy and hysterosal-
pingography. The general clinical data, surgical data and
sera were collected preoperatively and 1 month after
surgery. This study was approved by the Institutional
Review Board of the First Affiliated Hospital of Sun
Yat-sen University, and informed consent was obtained
from all of the patients.
For the endometrioma group (study group, group A)
and the other benign ovary cyst group (control 2, group C),
the inclusion criteria were as follows: (1) previous diag-
nostic procedures for ovarian tumors and histologically
confirmed endometriomas or other benign ovarian cysts;
(2) 20- to 40-year-old women with regular menstrual
cycles (21–35 days) at the time of the operation; and (3)
no evidence of any endocrine disorders, such as polycystic
ovarian syndrome (PCOS), diabetes mellitus, thyroid
dysfunction, hyperprolactinemia, congenital adrenal hyper-
plasia, Cushing’s syndrome, systemic lupus erythematosus
(SLE) or adrenal insufficiency. The exclusion criteria were
as follows: (1) postmenopausal status at the time of the
operation; (2) a history of adnexal surgery; (3) previous
history of adnexal surgery; (4) any suspicious findings of
malignant ovarian diseases; and (5) any hormone treatment
within 3 months prior to enrollment.
Our indications for surgery in the endometrioma group
were as follows: 1. infertility; 2. chronic pelvic pain; 3. cyst
size >5 cm lasting for more than two menstrual periods;
and 4.malignancy cannot be excluded. If the patients were
not infertile, then a cyst size >5 cm was the threshold. If
the patients were infertile, then cystectomy was performed
regardless of cyst size.
For the tubal factor infertility group (control 1, group B),
inclusion was based on infertility caused by the fallopian
tube (based on: 1. history; 2. ultrasound; 3. sex hormone
and ovulation supervision; 4. sperm analysis; and 5. hyster-
oscopy, laparoscopy and hysterosalpingography.), and cases
were excluded if a salpingectomy was performed during
the surgery or if there was any evidence of ovarian cysts or
endometriosis. All of the other inclusion and exclusion
criteria were the same as noted above.
Surgery
All of the women underwent the operation under general
anesthesia. Laparoscopic pneumoperitoneum was induced
by CO2 insufflation using a Veress needle that was passed
through a 1-cm umbilical incision until the intra-abdominal
pressure reached 12 mmHg. Following pneumoperitoneum,
umbilical 10-mm trocar and telescope entries were made.
Then, two trocars (5–10 mm) were inserted into both
suprainguinal regions under direct laparoscopic observation.
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termined whether the ovarian cyst was an endometrioma.
Then, the following steps were performed: incision of the
ovarian cyst with monopolar scissors, aspiration of the
contents of the cyst, and stripping of the cyst using two
atraumatic grasping forceps by traction and countertrac-
tion after the identification of the cleavage plane.
If the cyst was another type of benign cyst, then the
normal ovarian cortical tissues on the cysts were incised
to the level of the cyst capsule, and the cyst was removed
from the ovarian cortex by traction with a grasping forceps.
Every effort was made to remove the cyst without spilling
the contents.
Next, sutures were used to reapproximate the ovarian
edges and obtain hemostatic control. When necessary,
hemostasis was achieved with bipolar forceps applied to
the ovarian parenchyma. To reduce the possibility of dam-
age to the normal ovarian tissue, hemostatic procedures
were minimized. Following the removal of the ovarian cyst,
the specimens were assessed by visual examination for any
evidence of malignancy. Histological classification of the
specimens was then performed.
For the tubal infertility group, laparoscopic adhesiolysis,
hydrotubation and hysteroscopy were performed.
All of the laparoscopic procedures were performed by
the same skilled surgical team.Hormonal measurements
Serum samples from each patient were collected preopera-
tively and at 1 month after the surgery. The patients’ sera
were obtained from blood samples centrifuged at 3000 rpm
for 10 minutes to separate the cellular contents and debris.
The serum was transferred to sterile polypropylene tubes





Age (y) 30.38 ± 5.13 30.53 ±
BMI(kg/m2) 20.44 ± 2.55 21.19 ±
Gravidity 0.90 ± 0.18 1.00 ± 0
Cyst size (cm) 7.70 ± 3.66
Bilaterality (%) 16 (40)
Duration of operative procedure (min) 88.38 ± 45.27 50.50 ±
Blood loss (ml) 65.00 ± 44.89 30.56 ±
serum AMH (ng/ml)
Preoperative 1.53 ± 1.37a 2.82 ± 1
Postoperative 0.69 ± 0.89a 2.80 ± 1
Rate of decline 0.62 ± 0.35 0.02 ± 0
Note: 1). The cyst diameter refers to the average value of the maximum diamete
unilateral and refers to the sum of the diameters of the two cysts on both sides
level-postoperative AMH level)/preoperative AMH level. 3). For the paired rank-sum tesThe serum AMH concentration was measured using an
enzyme-linked immunosorbent assay (ELISA) kit accord-
ing to the manufacturer’s instructions (AMH ELISA; Ansh
Labs, UK). The minimum detectable concentration for
AMH was 0.06 ng/mL. Intra-assay coefficient of variation
was 0.02 (2.22/95); Inter-assay coefficient of variation was
7.81 (15.62/2).Statistical analysis
Categorical variables were presented as percentages and
were compared using the chi-squared test. Continuous
variables were presented as X  S. After the Kolmogorov-
Smirnov test, the preoperative serum AMH levels were
compared using the Kruskal-Wallis test, and changes
in the serum AMH levels after surgery were compared
within groups using the Wilcoxon matched-pairs signed
ranks sum test and between groups using the Mann–
Whitney U test.
Correlations between several factors and preoperative
serum AMH levels and the rate of decline of the AMH
levels in the endometrioma group, the infertility group
and the other benign ovarian cyst group were analyzed
by bivariate correlation analysis and were expressed as
Spearman correlation coefficients. Statistical analyses were
performed using Statistical Package for the Social Sciences
(SPSS, version 13.0). P < 0.05 was considered statistically
significant.Results
The clinical characteristics, preoperative AMH levels, post-
operative AMH levels, and rate of decline of the AMH
levels in the endometrioma group, the infertility group and
the other benign ovarian cyst group were summarized in
Table 1. The differences in age, body mass index (BMI),e three groups
actor infertility group
)
Other benign ovarian cyst group
(n = 22)
P
4.55 29.95 ± 3.92 0.89
2.58 20.19 ± 2.58 0.31
.22 0.91 ± 0.35 0.64
6.35 ± 2.88 0.15
4 (18) 0.08
31.84 67.95 ± 32.32 <0.001
21.80 28.64 ± 13.20 <0.001
.74c 2.20 ± 1.23b 0.001
.57c 1.48 ± 0.86b
.15 0.32 ± 0.30 <0.001
r line over two perpendicular planes of the ovarian cyst when the lesion is
when the lesions are bilateral. 2). AMH decline rate = (preoperative AMH
t of a and b, both P < 0.001. 4). For the paired rank-sum test of c, P = 0.48.
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statistically significant among the three groups, while the
differences in the operating time and intraoperative blood
loss were statistically significant (both P < 0.001); a further
comparison suggested that the operating time for group B
was the shortest (P < 0.001 and P = 0.02 compared with
group A and group C, respectively), whereas the difference
between groups A and C was statistically insignificant
(P = 0.08). The intraoperative blood loss was greatest in
group A (P < 0.001 compared to both groups), whereas
the difference between groups B and C was statistically
insignificant (P = 0.89).
The difference in preoperative serum AMH level among
the three groups was statistically significant (P = 0.001); a
further comparison indicated that the difference between
groups B and C was statistically insignificant (P = 0.29),
while the differences between groups A and B and between
groups A and C were statistically significant (P < 0.001 and
P = 0.02, respectively), indicating that the preoperative
serum AMH level in group A was lower than in the other
two groups.
Serum AMH levels were decreased at 1 month after
laparoscopic ovarian cystectomy in both groups A and C
(both P < 0.001), but not in group B (P = 0.48). The rate
of serum AMH level decline after surgery in the three
groups was significantly different (P < 0.001); a further
comparison indicated that the rate of serum AMH level
decline in group A was higher than in group C (P = 0.001),
and both were higher than in group B (both P < 0.001).
Several univariate analyses were performed to identify
factors that were statistically significantly correlated or
associated with the preoperative serum AMH and the rate
of decline of serum AMH levels (Table 2).
The preoperative AMH levels showed a significant cor-
relation with patient age (group A, r = −0.32; group B,
r = −0.54; group C, r = −0.71) but did not exhibit a signifi-
cant correlation with BMI, the diameter of the ovarian cystTable 2 Factors correlated with preoperative serum AMH leve
Preoperative serum AMH level
Endometrioma group Tubal factor
infertility group
P r P r







Unilateral 1.56 ± 1.17a 0.52
Bilateral 1.49 ± 1.66a
Note: a,b,c,dDerived from the Mann–Whitney U test for two independent samples.or the presence of unilateral/bilateral cysts in each group
(Figure 1A).
We did not observe any statistically significant correl-
ation between age or BMI and the rate of decline of the
AMH levels in the endometrioma group or the other be-
nign ovarian cyst group. However, the preoperative serum
AMH level and cyst size correlated with the rate of serum
AMH level decline in the endometrioma group (Figure 1C
and 1D) but not the other benign ovarian cyst group. In
addition, the rate of serum AMH level decline for bilateral
cysts was larger than for unilateral cysts in the endome-
trioma group but not in the other benign ovarian cyst
group (Figure 1B).
Because the rate of serum AMH level decline was cor-
related with cyst size in the endometrioma group, the
receiver operating characteristic (ROC) curve was then
determined using a serum AMH decline rate of 50% or
lower as a cut-off point. As shown in Figure 2, the area
under the ROC curve (AUC) was 0.72 (P = 0.01), indi-
cating that the sensitivity of a serum AMH level decline
of 50% or less after cystectomy was 85.7% for a patient
with an endometrioma ≤7 cm, and the corresponding
specificity was 68.0%. Additionally, the rate of decline
of the AMH level after surgery in the subgroup with
cysts >7 cm was significantly higher than in the subgroup
with cysts ≤7 cm (P = 0.001).
Discussion
Impact of endometriomas on ovarian reserve and
relevant factors
Endometrioma is a common gynecological disease. At
present, studies focusing on the impact of endometriomas
on ovarian reserve are controversial [9-12]. Therefore, we
conducted this study using patients with endometriomas
as the study group and patients with other benign ovarian
cysts or tubal factor infertility as controls. Our results
showed that the preoperative serum AMH levels in patientsl and the rate of decline level after surgery
The rate of decline of the AMH level
The other benign
ovarian cyst group
Endometrioma group The other benign
ovarian cyst group
P r P r P r
0.001 −0.71 0.09 0.84
0.16 0.98 0.37









2.28 ± 1.25b 0.47 0.46 ± 0.34c <0.001 0.32 ± 0.23d 0.60
1.66 ± 1.24b 0.85 ± 0.19c 0.33 ± 0.66d
Figure 1 Factors correlated with preoperative serum AMH level and the rate of decline level after surgery. A and B: Comparison of
preoperative serum AMH level and rate of serum AMH level decline between patients with unilateral and bilateral cysts in groups A and C. C
and D: Scatter plot of the correlation between the rate of serum AMH level decline, cyst size and the preoperative AMH level in the group A. The
preoperative AMH level showed no difference between unilateral and bilateral cysts in the two groups (Figure 1A). The rate of serum AMH level
decline for bilateral cysts was larger than for unilateral cyst in the endometrioma group but not the other benign ovarian cyst group (Figure 1B). The
preoperative serum AMH level and cyst size correlated with the rate of serum AMH level decline in the endometrioma group (Figures 1C and 1D).
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patients with tubal factor infertility or other benign ovar-
ian cysts, and there was no significant difference between
patients with other benign ovarian cysts and patients with
tubal factor infertility. These results indicate that, in con-
trast to other benign ovarian cysts, endometriomas per se
might damage the ovarian reserve. This finding could be
explained based on previous findings. For example, Muzii
[13] reported that the ovarian tissue adjacent to an endo-
metrioma was often destroyed and lost its typical follicularstructure, while the ovary tissue around other benign ovar-
ian cysts did not exhibit these changes. Stilley [14] stated
that peritoneal macrophages in patients with endometriosis
were dysfunctional and could secrete proteinases, dam-
aging the ovarian tissue and ultimately leading to a decline
in the ovarian reserve.
The analysis of the factors that affect the preoperative
serum AMH level showed that neither ovary cyst size nor
BMI was related to the preoperative serum AMH level.
There was also no relationship with the presence of
Figure 2 ROC for rate of serum AMH level decline and
endometrioma size. The area under the ROC curve (AUC) was
0.72 (P = 0.01), indicating that the sensitivity of the serum AMH
level declining by 50% or less after cystectomy was 85.7% for a
patient with an endometrioma ≤7 cm, and the corresponding
specificity was 68.0%.
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tients in all three groups, the preoperative serum AMH
was negatively correlated with age, indicating that age was
the main factor that affected the basal ovarian reserve,
which is consistent with recent studies [15].
Impact of cystectomy on the ovarian reserve and the
analysis of relevant factors
Cystectomy is currently the first option for treating ovar-
ian endometriomas [16], but it remains controversial
whether the surgery itself decreases the ovarian reserve
[17-23]. In this study, the results indicated that for both
the patients with endometriomas and patients with other
benign ovarian cysts, the serum AMH levels 1 month after
cystectomy were statistically significantly lower than the
preoperative levels, indicating that cystectomy might do
harm to the ovarian reserve. In addition, the serum AMH
level declined more in the endometrioma patients than in
patients with other benign ovarian cysts, implying that the
greater damage to the ovarian reserve caused by cystectomy
of endometriomas compared with other benign ovarian
cysts might be attributed to the intrinsic characteristics
of endometriomas themselves. The pathogenic mechanisms
were as follows: 1) inversion and progressive invagination
of the ovarian cortex after the accumulation of menstrual
debris deriving from bleeding of superficial endometriotic
implants [24] and 2) secondary involvement of func-
tional ovarian cysts by endometrial implants located onthe ovarian surface [25]. Both theories suggest that the
boundary between the endometrial cyst wall and the
surrounding normal ovarian tissue is unclear, unlike the
boundary in other benign ovarian cysts; thus, removal
may cause greater damage to the ovarian reserve. More-
over, the intraoperative blood loss was greater and the op-
erative time was longer in the endometrioma group than
in the other benign ovarian cyst group, indirectly indicat-
ing that the boundaries between the endometrial cyst and
the surrounding ovarian tissue are unclear and that the
surgery is more difficult, which supports the suggestion
that the surgical removal of endometriomas leads to a
higher risk of damaging the ovarian reserve.
Although cystectomy of endometriomas is more likely
to damage the ovarian reserve, it is still the first option for
treating an endometrioma. One reason is that we cannot
completely exclude the possibility of malignant ovarian
masses because preoperative pathological examinations
are not usually conducted. Moreover, previous studies [26]
have confirmed that the risk of ovarian cancer in patients
with endometrioma is double the risk in the normal popu-
lation, and the risk increases to four times when ac-
companied by infertility. In addition, during the in vitro
fertilization/embryo transfer (IVF/ET) process for infer-
tile patients with endometriomas, there is the risk of
unintentionally rupturing the endometrioma during
oocyte retrieval, which could cause contamination and
infection [27].
To reduce the damage to the ovarian reserve caused by
cystectomy, in addition to improving surgical skills, we
should also pay attention to the relevant factors that affect
the damage. In this study, the size of the endometrioma
and the presence of bilateral endometriomas were both
positively related to the rate of decline of the serum AMH
level, whereas this correlation was not observed in patients
with other benign ovarian cysts. This result suggested that
the removal of bilateral or relatively large endometriomas
would cause relatively significant damage to the ovarian
reserve. Because of the unclear boundaries between the
endometrioma and surrounding ovarian tissue, when the
endometrioma is large or is bilateral, the contact area with
normal ovarian tissue is large. Consequently, during the
surgical removal of the endometrial cyst, it is more likely
that a greater amount of the surrounding normal ovarian
tissue or the cortex will be removed, causing greater dam-
age to the ovarian reserve. Additionally, further analysis
indicated that the serum AMH level after cystectomy of a
unilateral endometrioma with a diameter ≤7 cm or bilat-
eral endometrial cysts with total diameters ≤7 cm declined
less than for measurements >7 cm. All of these results
suggested that ovarian endometriomas should be diagnosed
and treated as early as possible, which supports the sugges-
tion of Kitajima et al. [28]. Moreover, the results also indi-
cated that age was negatively related to the preoperative
Chen et al. Journal of Ovarian Research 2014, 7:108 Page 7 of 8
http://www.ovarianresearch.com/content/7/1/108serum AMH level, although it was not correlated with the
rate of decline of the serum AMH level after endometrioma
cystectomy. The preoperative serum AMH level itself was
negatively related to the decline of serum AMH level
following surgery. Therefore, this result implied that it
was necessary to measure the preoperative ovarian reserve
prior to cystectomy in older patients. If the preoperative
serum AMH is too low, then we should consider evaluating
the risk of postoperative ovarian failure.
Conclusions
In summary, ovarian endometrioma per se may damage
the ovarian reserve, and compared with other benign ovar-
ian cysts, cystectomy of endometriomas can cause greater
damage to the ovarian reserve. This finding supports the
idea that ‘endometriosis itself may cause the decline in
serum AMH levels, and surgery contributes to this decline
by harming healthy ovarian cortex’. The surgery-related
damage to the ovarian reserve is positively related to
whether the endometriomas are bilateral and to the cyst
size and is negatively related to the preoperative serum
AMH level of the patients. Age itself is a negative factor
that affects the ovarian reserve. Therefore, the treatment
plan for patients with ovarian endometrioma should com-
bine individual factors, such as the child-bearing demand,
age, characteristics of the cyst and baseline serum AMH
level; furthermore, gynecological and reproductive endo-
crine doctors should work together to develop more ra-
tional treatment programs and to provide more guidance
for reproductive health care.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
YC participated in the conception and design of the study and the analysis
and interpretation of data. HP and YC participated in the acquisition and
analysis of the data and in drafting the manuscript. MC and HW participated
in revising the manuscript. HX and SY participated in conducting the
surgeries. All authors read and approved the final manuscript.
Acknowledgements
We thank the following sources for funding:
1. Science and Technology Planning Project of Guangdong Province, China
(20120401).
2. Science and Technology Planning Project of Guangzhou, China
(12A022061820).
Author details
1The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. 2The
People’s Hospital of Anyang City, Anyang, China. 3The Sixth Affiliated
Hospital, Sun Yat-sen University, Guangzhou, China.
Received: 22 June 2014 Accepted: 6 November 2014
References
1. de Ziegler D, Borghese B, Chapron C: Endometriosis and infertility:
pathophysiology and management. Lancet 2010, 376(9742):730–738.
2. Busacca M, Vignali M: Endometrioma excision and ovarian reserve: a
dangerous relation. J Minim Invasive Gynecol 2009, 16(2):142–148.3. Ruiz-Flores FJ, Garcia-Velasco JA: Is there a benefit for surgery in
endometrioma-associated infertility? Curr Opin Obstet Gynecol 2012,
24(3):136–140.
4. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R, Taieb J:
Serum anti-Mullerian hormone is more strongly related to ovarian
follicular status than serum inhibin B, estradiol, FSH and LH on day 3.
Hum Reprod 2003, 18(2):323–327.
5. Hehenkamp WJ, Looman CW, Themmen AP, de Jong FH, Te VE, Broekmans FJ:
Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not
show substantial fluctuation. J Clin Endocrinol Metab 2006, 91(10):4057–4063.
6. La Marca A, Stabile G, Artenisio AC, Volpe A: Serum anti-Mullerian hormone
throughout the human menstrual cycle. Hum Reprod 2006, 21(12):3103–3107.
7. Deb S, Campbell BK, Pincott-Allen C, Clewes JS, Cumberpatch G, Raine-Fenning NJ:
Quantifying effect of combined oral contraceptive pill on functional
ovarian reserve as measured by serum anti-Mullerian hormone and
small antral follicle count using three-dimensional ultrasound.
Ultrasound Obstet Gynecol 2012, 39(5):574–580.
8. Kristensen SL, Ramlau-Hansen CH, Andersen CY, Ernst E, Olsen SF, Bonde JP,
Vested A, Toft G: The association between circulating levels of antimullerian
hormone and follicle number, androgens, and menstrual cycle characteristics
in young women. Fertil Steril 2012, 97(3):779–785.
9. Kuroda M, Kuroda K, Arakawa A, Fukumura Y, Kitade M, Kikuchi I, Kumakiri J,
Matsuoka S, Brosens IA, Brosens JJ, Takeda S, Yao T: Histological assessment of
impact of ovarian endometrioma and laparoscopic cystectomy on ovarian
reserve. J Obstet Gynaecol Res 2012, 38(9):1187–1193.
10. Pacchiarotti A, Frati P, Milazzo GN, Catalano A, Gentile V, Moscarini M:
Evaluation of serum anti-Mullerian hormone levels to assess the ovarian
reserve in women with severe endometriosis. Eur J Obstet Gynecol Reprod
Biol 2014, 172:62–64.
11. Streuli I, de Ziegler D, Gayet V, Santulli P, Bijaoui G, de Mouzon J, Chapron C: In
women with endometriosis anti-Mullerian hormone levels are decreased
only in those with previous endometrioma surgery. Hum Reprod 2012,
27(11):3294–3303.
12. Benaglia L, Pasin R, Somigliana E, Vercellini P, Ragni G, Fedele L:
Unoperated ovarian endometriomas and responsiveness to
hyperstimulation. Hum Reprod 2011, 26(6):1356–1361.
13. Muzii L, Bianchi A, Croce C, Manci N, Panici PB: Laparoscopic excision of
ovarian cysts: is the stripping technique a tissue-sparing procedure?
Fertil Steril 2002, 77(3):609–614.
14. Stilley JA, Birt JA, Sharpe-Timms KL: Cellular and molecular basis for
endometriosis-associated infertility. Cell Tissue Res 2012, 349(3):849–862.
15. Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F: Age-specific
serum anti-Mullerian hormone levels: estimates from a large population-
based sample. Climacteric 2014, 17(5):591–597.
16. Chapron C, Fauconnier A, Goffinet F, Breart G, Dubuisson JB: Laparoscopic
surgery is not inherently dangerous for patients presenting with benign
gynaecologic pathology. Results of a meta-analysis. Hum Reprod 2002,
17(5):1334–1342.
17. Litta P, D’Agostino G, Conte L, Saccardi C, Cela V, Angioni S, Plebani M:
Anti-Mullerian hormone trend after laparoscopic surgery in women with
ovarian endometrioma. Gynecol Endocrinol 2013, 29(5):452–454.
18. Takashima A, Takeshita N, Otaka K, Kinoshita T: Effects of bipolar
electrocoagulation versus suture after laparoscopic excision of ovarian
endometrioma on the ovarian reserve and outcome of in vitro
fertilization. J Obstet Gynaecol Res 2013, 39(7):1246–1252.
19. Sugita A, Iwase A, Goto M, Nakahara T, Nakamura T, Kondo M, Osuka S, Mori M,
Saito A, Kikkawa F: One-year follow-up of serum antimullerian hormone
levels in patients with cystectomy: are different sequential changes due to
different mechanisms causing damage to the ovarian reserve? Fertil Steril
2013, 100(2):516–522.
20. Muzii L, Di Tucci C, Di Feliciantonio M, Marchetti C, Perniola G, Panici PB:
The effect of surgery for endometrioma on ovarian reserve evaluated by
antral follicle count: a systematic review and meta-analysis. Hum Reprod
2014, 29:2190–2198.
21. Lee DY, Young KN, Jae KM, Yoon BK, Choi D: Effects of laparoscopic
surgery on serum anti-Mullerian hormone levels in reproductive-aged
women with endometrioma. Gynecol Endocrinol 2011, 27(10):733–736.
22. Celik HG, Dogan E, Okyay E, Ulukus C, Saatli B, Uysal S, Koyuncuoglu M:
Effect of laparoscopic excision of endometriomas on ovarian reserve:
serial changes in the serum antimullerian hormone levels. Fertil Steril
2012, 97(6):1472–1478.
Chen et al. Journal of Ovarian Research 2014, 7:108 Page 8 of 8
http://www.ovarianresearch.com/content/7/1/10823. Tsolakidis D, Pados G, Vavilis D, Athanatos D, Tsalikis T, Giannakou A,
Tarlatzis BC: The impact on ovarian reserve after laparoscopic ovarian
cystectomy versus three-stage management in patients with endometriomas:
a prospective randomized study. Fertil Steril 2010, 94(1):71–77.
24. Durlinger AL, Visser JA, Themmen AP: Regulation of ovarian function: the
role of anti-Mullerian hormone. Reproduction 2002, 124(5):601–609.
25. Nelson SM, Anderson RA, Broekmans FJ, Raine-Fenning N, Fleming R, La Marca A:
Anti-Mullerian hormone: clairvoyance or crystal clear? Hum Reprod 2012,
27(3):631–636.
26. Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM,
Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G,
Wilkens LR, Carney ME, Goodman MT, Moysich K, Kjaer SK, Hogdall E, Jensen A,
Goode EL, Fridley BL, Larson MC, Schildkraut JM, Palmieri RT, Cramer DW,
Terry KL, Vitonis AF, Titus LJ, Ziogas A, et al: Association between endometriosis
and risk of histological subtypes of ovarian cancer: a pooled analysis
of case–control studies. Lancet Oncol 2012, 13(4):385–394.
27. Nargund G, Parsons J: Infected endometriotic cysts secondary to oocyte
aspiration for in-vitro fertilization. Hum Reprod 1995, 10(6):1555.
28. Kitajima M, Khan KN, Hiraki K, Inoue T, Fujishita A, Masuzaki H: Changes in
serum anti-Mullerian hormone levels may predict damage to residual
normal ovarian tissue after laparoscopic surgery for women with ovarian
endometrioma. Fertil Steril 2011, 95(8):2589–2591.
doi:10.1186/s13048-014-0108-0
Cite this article as: Chen et al.: The impact of endometrioma and
laparoscopic cystectomy on ovarian reserve and the exploration of related
factors assessed by serum anti-Mullerian hormone: a prospective cohort
study. Journal of Ovarian Research 2014 7:108.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
